TrialNature communications2024

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.

Michael D Keller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.